Sonoma Pharmaceuticals, Inc. earnings releases SNOA

Annual Quarterly

Sonoma Pharmaceuticals, Inc. last reported quarterly results on Nov 8, 2018, for the quarter ended Sep 30, 2018. It usually reports 38–74 days after a quarter ends.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 38–74 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released	Quarter	Revenue	Net income	Diluted EPS
Nov 8, 2018 39 days after quarter end	— ended Sep 30, 2018	—	—	—
Aug 8, 2018 39 days after quarter end	— ended Jun 30, 2018	—	—	—
Jun 13, 2018 74 days after quarter end	— ended Mar 31, 2018	—	—	—
Feb 7, 2018 38 days after quarter end	— ended Dec 31, 2017	—	—	—
Nov 9, 2017 40 days after quarter end	— ended Sep 30, 2017	—	—	—
Aug 8, 2017 39 days after quarter end	— ended Jun 30, 2017	—	—	—
Jun 5, 2017 66 days after quarter end	— ended Mar 31, 2017	—	—	—
Feb 9, 2017 40 days after quarter end	— ended Dec 31, 2016	—	—	—

Company profile

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as: SNOA (Nasdaq)
Fiscal year ends: March 31
Incorporated in: DE
Headquarters: Boulder, CO
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1367083
Former names: Oculus Innovative Sciences, Inc. (until Dec 2, 2016)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.